Nurse Practitioner CE requirements by state
How nurse practitioners renew in each state: cycle, deadline basis, continuing education hours, and mandated topics. 44 of 51 jurisdictions verified so far; the rest are coming soon and are not estimated.
Jump to a state for nurse practitioners
Verified states
| State | Renewal | Deadline | CE per cycle | Mandated topics | Verified |
|---|---|---|---|---|---|
| Alabama | Two-year | Same date for every licensee | 24 contact hours | Pharmacology continuing education for advanced practice nurses; Continuing education on the rules and statutes governing collaborative practice in Alabama; Controlled substance prescribing CME for holders of a Qualified Alabama Controlled Substances Certificate (QACSC) | September 8, 2026 |
| Arizona | 48-month | Same date for every licensee | None | Opioid related, substance use disorder related or addiction related continuing education; Pharmacology and clinical management of drug therapy | September 8, 2026 |
| Arkansas | Two-year | Tied to the licensee's birth date | 15 contact hours | Pharmacotherapeutics continuing education in the APRN's area of certification; Professional boundaries, substance abuse and misuse, and the prescribing rules, regulations and laws that apply to APRNs in Arkansas | September 8, 2026 |
| California | Two-year | Tied to the licensee's birth month | 30 contact hours | Gerontology, the special care needs of patients with dementia, or the care of older patients; Implicit bias course; Schedule II controlled substances and the risks of addiction associated with their use | September 8, 2026 |
| Colorado | Two-year | Same date for every licensee | 2 contact hours | Substance use prevention training | September 8, 2026 |
| Connecticut | Annual | Tied to the licensee's birth month | 50 contact hours every two years | Pharmacotherapeutics; Infectious diseases, including but not limited to acquired immune deficiency syndrome and human immunodeficiency virus; Risk management; Sexual assault; Domestic violence; Cultural competency; Substance abuse, including but not limited to prescribing controlled substances and pain management; Mental health conditions common to veterans and family members of veterans, including screening for post-traumatic stress disorder, risk of suicide, depression and grief, and suicide prevention training | September 8, 2026 |
| Delaware | Two-year | Board-specific schedule | 30 contact hours | Substance abuse; Recognition of and response to suspected or known sexual abuse, physical abuse, exploitation, trafficking, or domestic violence; Controlled substance prescribing practices, treatment of chronic pain, or other topics related to prescribing controlled substances | September 8, 2026 |
| Florida | Two-year | Board-specific schedule | 24 contact hours | Prevention of Medical Errors; Florida Laws and Rules; Recognition of Impairment in the Workplace; Human Trafficking; Safe and Effective Prescription of Controlled Substances; Domestic Violence; HIV/AIDS | September 8, 2026 |
| Georgia | Two-year | Same date for every licensee | 30 contact hours | None listed | September 8, 2026 |
| Hawaii | Two-year | Same date for every licensee | 30 contact hours | Pharmacology | September 8, 2026 |
| Illinois | Two-year | Same date for every licensee | 80 contact hours | Pharmacotherapeutics; Opioid prescribing or substance abuse education; Sexual harassment prevention training; Implicit bias awareness training; Cultural competency training; Alzheimer's disease and other dementias training | September 8, 2026 |
| Indiana | Two-year | Same date for every licensee | 30 contact hours | Pharmacology | September 8, 2026 |
| Iowa | Three-year | Tied to the licensee's birth month | 36 contact hours | Continuing education on the CDC guidelines for prescribing opioids for chronic pain; Mandatory reporter training, child abuse identification and reporting; Mandatory reporter training, dependent adult abuse identification and reporting | September 8, 2026 |
| Kansas | Two-year | Tied to the licensee's birth month | 30 contact hours | None listed | September 8, 2026 |
| Kentucky | Annual | Same date for every licensee | 14 contact hours | Pharmacology; Pain management or addiction disorders, inside the five pharmacology hours; Treating and managing patients with opioid or other substance use disorders; Pediatric abusive head trauma; Domestic violence and elder abuse, neglect, and exploitation; Alzheimer's disease and other forms of dementia; Suicide prevention | September 8, 2026 |
| Louisiana | Two-year | Same date for every licensee | 30 contact hours | Pharmacotherapeutics in the APRN's advanced nursing role and population foci; Controlled substance prescribing practices | September 8, 2026 |
| Maine | Two-year | Tied to the licensee's birth date | 50 CEUs | Pharmacology CEUs for an APRN who has not prescribed | September 8, 2026 |
| Maryland | Two-year | Tied to the licensee's birth month | 30 CEUs | Implicit bias and structural racism training | September 8, 2026 |
| Massachusetts | Two-year | Tied to the licensee's birth date | 15 contact hours | Diagnosis, treatment and care of patients with cognitive impairments, including Alzheimer's disease and dementia; Prescriber training on pain management and opioid misuse | September 8, 2026 |
| Michigan | Two-year | Tied to the original issue date | 25 contact hours | Pain and pain symptom management; Implicit bias training; Opioids and other controlled substances awareness training; Training in identifying victims of human trafficking | September 8, 2026 |
| Minnesota | Two-year | Tied to the licensee's birth month | 24 contact hours | None listed | September 8, 2026 |
| Mississippi | Two-year | Same date for every licensee | 5 contact hours | Continuing education directly related to controlled substances | September 8, 2026 |
| Missouri | Two-year | Same date for every licensee | None | None listed | September 8, 2026 |
| Montana | Two-year | Same date for every licensee | None | None listed | September 8, 2026 |
| Nebraska | Two-year | Same date for every licensee | 20 contact hours | Continuing education regarding prescribing opiates, including the prescription drug monitoring program | September 8, 2026 |
| Nevada | Two-year | Tied to the licensee's birth date | 45 contact hours | Cultural competency and diversity, equity and inclusion; Medical consequences of an act of terrorism involving a weapon of mass destruction; Suicide prevention; Opioid training; Stigma, discrimination and unrecognized bias toward persons who have or are at high risk of acquiring HIV; Screening, brief intervention and referral to treatment approach to substance use disorder | September 8, 2026 |
| New Hampshire | Two-year | Tied to the licensee's birth date | 60 contact hours | Education in pharmacology; Pain management and addiction disorder, or a combination of the two | September 8, 2026 |
| New Mexico | Two-year | Tied to the licensee's birth month | 45 contact hours | Pharmacology; Management of non-cancer pain | September 8, 2026 |
| New York | Three-year | Tied to the licensee's birth month | None | Coursework or training in infection control and barrier precautions to prevent transmission of HIV and hepatitis B; Coursework or training in the identification and reporting of child abuse and maltreatment; Mandatory prescriber education in pain management, palliative care and addiction | September 8, 2026 |
| North Carolina | Annual | Tied to the licensee's birth month | 50 contact hours every two years | Continuing education on controlled substance prescribing practices, chronic pain management, recognition of abuse, or non-opioid alternatives | September 8, 2026 |
| North Dakota | Two-year | Board-specific schedule | 15 contact hours | Pharmacotherapy related to scope of practice | September 8, 2026 |
| Ohio | Two-year | Same date for every licensee | 48 contact hours | Advanced pharmacology; Category A continuing education on Ohio nursing law and rules | September 8, 2026 |
| Oregon | Two-year | Tied to the original issue date | Required, hours not stated | Pain management education; Cultural competency education | September 8, 2026 |
| Pennsylvania | Two-year | Board-specific schedule | 30 contact hours | Child abuse recognition and reporting; Pharmacology; Pain management, the identification of addiction, or the practices of prescribing or dispensing opioids; Organ and tissue donation and recovery process | September 8, 2026 |
| Rhode Island | Two-year | Same date for every licensee | 10 contact hours | Substance abuse; Alzheimer's disease training; Eight hours of training on the treatment and management of patients with opioid or other substance use disorders | September 8, 2026 |
| South Carolina | Two-year | Same date for every licensee | 30 contact hours | Continuing education in pharmacotherapeutics; Prescribing controlled substances | September 8, 2026 |
| South Dakota | Two-year | Tied to the licensee's birth date | None | None listed | September 8, 2026 |
| Texas | Two-year | Tied to the licensee's birth month | 20 contact hours | Pharmacotherapeutics; Safe and effective pain management related to the prescription of opioids and other controlled substances; Approved procedures of prescribing and monitoring controlled substances; Nursing jurisprudence and nursing ethics; Older adult or geriatric care; Human trafficking prevention; Forensic evidence collection | September 8, 2026 |
| Utah | Two-year | Same date for every licensee | 0.5 contact hours | Online suicide prevention training; Controlled substance continuing education | September 8, 2026 |
| Virginia | Two-year | Tied to the licensee's birth month | 8 contact hours | Pharmacology or pharmacotherapeutics | September 8, 2026 |
| Washington | Two-year | Tied to the licensee's birth date | 45 contact hours | Pharmacotherapeutics; Best practices in the prescribing of opioids; Health equity continuing education, including implicit bias training; Training in suicide assessment, treatment, and management | September 8, 2026 |
| West Virginia | Two-year | Same date for every licensee | 24 contact hours | Pharmacotherapeutics (advanced pharmacology); Clinical management of patients: assessment, diagnosis, planning and evaluation; Drug diversion training, best practice prescribing of controlled substances, and prescribing and administering an opioid antagonist | September 8, 2026 |
| Wisconsin | Two-year | Same date for every licensee | 16 contact hours | Clinical pharmacology or therapeutics relevant to the prescriber's area of practice; Responsible prescribing of controlled substances | September 8, 2026 |
| Wyoming | Two-year | Same date for every licensee | 3 contact hours | Responsible prescribing of controlled substances or treatment of substance use disorders | September 8, 2026 |
Coming soon
7 jurisdictions are coming soon for nurse practitioners.
- Alaska
- District of Columbia
- Idaho
- New Jersey
- Oklahoma
- Tennessee
- Vermont